Abstract
RNA interference (RNAi) is a process by which introduced small interfering RNA (siRNA) can cause the specific degradation of mRNA with identical sequences. The human herpes simplex virus type 1 (HSV-1) RR is composed of two distinct homodimeric subunits encoded by UL39 and UL40, respectively. In this study, we applied siRNAs targeting the UL39 and UL40 genes of HSV-1. We showed that synthetic siRNA silenced effectively and specifically UL39 and UL40 mRNA expression and inhibited HSV-1 replication. Our work offers new possibilities for RNAi as a genetic tool for inhibition of HSV-1 replication.
This is a preview of subscription content, access via your institution.
References
Andino R. 2003. RNAi puts a lid on virus replication. Nat Biotechnol, 21: 629–630.
Bhuyan P K, Kariko K, Capodici J. 2004. Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes. J Virol, 78: 10276–10281.
Brandt C R, Kintner R L, Pumfrey A M, et al. 1991. The herpes simplex virus ribonucleotide reductase is required for ocular virulence. J Gen Virol, 72: 2043–2049.
Cameron J M, Mcdougall I, Marsden H S, et al. 1988. Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J Gen Virol, 69: 2607–2612.
Cory J G. 1988. Ribonucleotide reductase as a chemotherapeutic target. Adv Enzyme Regul, 27: 437–455.
David J G, Sandra K W. 1988. Herpes Simplex Virus Type 1-Induced Ribonucleotide Reductase Activity Is Dispensable for Virus Growth and DNA Synthesis: Isolation and Characterization of an ICP6 lacZ Insertion Mutant. J Virol, 62: 196–205.
Elbashir S M, Harborth J, Weber K, et al. 2002. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods, 26: 199–213.
Frame M C, Marsden H S, Dutia B M. 1985. The ribonucleotide reductase induced by herpes simplex virus type 1 involves minimally a complex of two polypeptides (136K and 38K). J Gen Virol, 66: 1581–1587.
Honess R.W, Roizman B. 1973. Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and non-structural herpes virus polypeptides in infected cells. J Virol, 12: 1347–1365.
Honess R W, Roizman B. 1974. Regulation of herpes virus macromolecular synthesis.I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol. 14:8–19.
Holen T, Amarzguioui M, Wiiger M T, et al. 2002. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res, 30: 1757–1766.
Idowu A D, Fraser-Smith E B, Poffenberger K L, et al. 1992. Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo. Antiviral Res, 17: 145–156.
Ingemarson R, Lankinen H. 1987. The herpes simplex virus type 1 ribonucleotide reductase is a tight complex of the type alpha 2 beta 2 composed of 40K and 140K proteins, of which the latter shows multiple forms due to proteolysis. Virology, 156: 417–422.
Jacobson J G, Leib A D, Goldstein D J, et al. 1989. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology, 173: 276–283.
Jiang M, Milner J. 2002. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene, 21: 6041–6048.
Kawasaki H, Suyama E, Iyo M, et al 2003. siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells. Nucl Acids Res, 31: 981–987.
Khvorova A, Reynolds A, Jayasena S D. 2003. Functional siRNAs and rniRNAs exhibit strand bias. Cell, 115: 209–216.
Livak K J, Schmittgen T D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔCT). Methods, 25: 402–408
Luo K Q, Chang DC. 2004. The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region. Biochem Biophys Res Commun, 318: 303–310.
Mcgeoch D J, Dalrymple M A, Davison A J, et al. 1988. The complete DNA sequences of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol, 69: 1531–1574.
Preston V G, Coates J A, Rixon F J. 1983. Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA. J Virol, 45: 1056–1064.
Preston V G, Palfreyman J W, Dutia B M. 1984. Identification of a herpes simplex virus type 1 polypeptide which is a component of the virus-induced ribonucleotide reductase. J Gen Virol, 65: 1457–1466
Pu Y, Liu L D, Ma S H. 2005. Analysis of siRNA interfering in the alpha 22 immediate early gene of HSV-1. Virol Sin, 20: 221–224.
Ren Z, Zhang M Y, Kitazato K, et al. 2008. Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA. Arch Virol. 153: 1401–1406.
Ren Z, Zhang C H, Wang L J, et al. 2010. In Vitro Anti-viral Activity of the Total Alkaloids from Tripterygium Hypoglaucum against Herpes Simplex Virus Type 1. Virol Sin, 25: 107–114.
Robins M J. 1999. Mechanism-based inhibition of ribonucleotide reductases: new mechanistic considerations and promising biological applications. Nucleosides Nucleotides, 18: 779–793.
Schubert S, Grunweller A, Erdmann V A, et al 2005. Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions. J Mol Bio, 348: 883–893.
Song E, Lee S K, Wang J, et al. 2003. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med, 9: 347–351.
Szekeres T, Fritzer-Szekeres M, Elford H L. 1997. The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapy. Crit Rev Clin Lab Sci, 34: 503–528.
Thelander L, Reichard P. 1979. Reduction of ribonucleotides. Annu Rev Biochem, 48:133–158.
Vickers T A, Koo S, Bennett C F, et al 2003. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J Biol Chem, 278: 7108–7118.
Yamada Y, Kimura H, Morishima T, et al. 1991. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice. J Infect Dis, 164: 1091–1097.
Zhu Q C, Ren Z, Zhang C Let al. 2007. Silencing HSV-1 gD expression in cultured cells by RNA interference. Chin J Virol, 23: 22–27.
Author information
Authors and Affiliations
Corresponding authors
Additional information
These authors contributed equally to this work.
Foundation items: The Nation “863” Program of China (2006AA02A226); The Joint Funds of National Science Foundation of China (U0632010); The State Key Laboratory of Phytochemistry and Plant Resources in West China; Chinese Academy of Sciences (O807 B11211, O807E21211) and “211 grant of MOE”.
Rights and permissions
About this article
Cite this article
Ren, Z., Li, S., Wang, Ql. et al. Effect of siRNAs on HSV-1 plaque formation and relative expression levels of RR mRNA. Virol. Sin. 26, 40–46 (2011). https://doi.org/10.1007/s12250-011-3162-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-011-3162-9
Key words
- Small interfering RNA (siRNA)
- Herpes simplex virus type I (HSV-1)
- Ribonucleotide reductase (RR)
- Gene